Neuroblastoma and cell communication networks
11 Dec 2017
Neuroblastoma and cell communication networks
Personalised medicine differs from precision medicine
Approaches to screening and early detection across Europe
Connecting personalised medicine research in Canada with Europe
Cancer Core Europe
Roche joining forces to forward precision oncology
Effective implementation of personalised medicine guidelines
Epidemiology data for acute myeloid leukaemia and the ALESE study
Shortening the time to manufacture CAR T-cells
ASPIRE update: Carfilzomib triplet for relapsed / refractory myeloma
Six-month follow up of CTL019 for diffuse large B-cell lymphoma
Anti-BCMA CAR T cell therapy for multiple myeloma